TCTAP 2026 Sponsors

Johnson and Johnson MedTech

Logo
For over 140 years, Johnson and Johnson has been working alongside clinicians and patients to reimagine healthcare. Today, we are at the forefront of medtech innovation, developing the next generation of smarter, less invasive, more personalized treatments to tackle the most pervasive and complex health challenges.

Satellite Symposium

Lunchtime Activities

Impella CP in Cardiogenic Shock : Evidence and Best Practice

Organized by CVRF and Supported by Educational Grant From Johnson and Johnson MedTech

Friday, May 1
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Room 203, Level 2
12:20 PM DanGer Shock and AMICS Guideline Updates : Where Do We Stand?
Lecturer: Jeehoon Kang
12:35 PM Paving the Way for Heart Recovery in Korea: Impella Early Learnings and Progress
Lecturer: Min Chul Kim
12:50 PM Shock Treatment Journey in Japan: Evolving Indication and Impella's role in AMICS
Lecturer: Toshiro Shinke
1:05 PM Q&A